Biguanides: A new potential therapeutic option for pituitary tumors?
Mari C. Vázquez‐Borrego(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Raúl M. Luque(Instituto de Salud Carlos III), Eva Venegas‐Moreno(Hospital Universitario Virgen del Rocío), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Justo P. Castaño(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Alfonso Soto‐Moreno(Instituto de Biomedicina de Sevilla), Ma Ángeles Gálvez(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
|Pharmacological Reviews|2018|251